Severe Cutaneous Adverse Reaction to Piperacillin-Tazobactam: A Case of Stevens-Johnson Syndrome

被引:1
作者
Kumar, Hansraj [1 ]
Kumar, Alok [2 ]
Kumar, Subodh [3 ]
机构
[1] AIIMS Deoghar, Pharmacol & Therapeut, Deoghar, India
[2] Shahid Nirmal Mahto Med Coll Hosp SNMMCH, Pathol & Lab Med, Dhanbad, India
[3] AIIMS Deoghar, Pharmacology, Deoghar, India
关键词
stevens-johnson syndrome; piperacillin-tazobactam; drug reaction; intravenous antibiotics; acute appendicitis; TOXIC EPIDERMAL NECROLYSIS;
D O I
10.7759/cureus.42839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stevens-Johnson syndrome (SJS) is a rare condition characterized by an exaggerated immune system response to triggers such as infections or drugs. It is characterized by blistering and exfoliation of the skin and affects mucosal surfaces, including the eyes, buccal cavity, and genitals. We report a case of a 50-year -old male who developed symptoms of SJS following a recent hospital admission for acute appendicitis The patient presented with fever, erythematous patches on the palms, abdomen, groins, and oral mucosa. The onset of symptoms occurred approximately four days after discharge from the hospital, where the patient had received treatment including intravenous antibiotics (Piperacillin-Tazobactam), ranitidine, tramadol, and intravenous fluids. He was diagnosed with SJS based on clinical and histopathological findings and was treated with supportive care and corticosteroids. He recovered after one week of hospitalization. This case highlights the importance of recognizing the potential risk of developing SJS following drug administration and the need for prompt identification and management of the condition to prevent complications and improve patient outcomes.
引用
收藏
页数:4
相关论文
共 8 条
  • [1] Ergen Elizabeth Noble, 2017, JAMA Dermatol, V153, P1344, DOI 10.1001/jamadermatol.2017.3957
  • [2] Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children
    Finkelstein, Yaron
    Soon, Gordon S.
    Acuna, Patrick
    George, Mathew
    Pope, Elena
    Ito, Shinya
    Shear, Neil H.
    Koren, Gideon
    Shannon, Michael W.
    Garcia-Bournissen, Facundo
    [J]. PEDIATRICS, 2011, 128 (04) : 723 - 728
  • [3] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management
    Frantz, Robert
    Huang, Simo
    Are, Abhirup
    Motaparthi, Kiran
    [J]. MEDICINA-LITHUANIA, 2021, 57 (09):
  • [4] Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis
    Fritsch P.O.
    Sidoroff A.
    [J]. American Journal of Clinical Dermatology, 2000, 1 (6) : 349 - 360
  • [5] Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature
    Letko, E
    Papaliodis, DN
    Papaliodis, GN
    Daoud, YJ
    Ahmed, AR
    Foster, CS
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (04) : 419 - 436
  • [6] LiverTox, 2012, LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
  • [7] Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
    Mockenhaupt, Maja
    Viboud, Cecile
    Dunant, Ariane
    Naldi, Luigi
    Halevy, Sima
    Bavinck, Jan Nico Bouwes
    Sidoroff, Alexis
    Schneck, Jurgen
    Roujeau, Jean-Claude
    Flahault, Antoine
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (01) : 35 - 44
  • [8] TOXIC EPIDERMAL NECROLYSIS - CLINICAL FINDINGS AND PROGNOSIS FACTORS IN 87 PATIENTS
    REVUZ, J
    PENSO, D
    ROUJEAU, JC
    GUILLAUME, JC
    PAYNE, CR
    WECHSLER, J
    TOURAINE, R
    [J]. ARCHIVES OF DERMATOLOGY, 1987, 123 (09) : 1160 - 1165